focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 264.00
Bid: 262.50
Ask: 264.00
Change: -8.00 (-2.94%)
Spread: 1.50 (0.571%)
Open: 268.00
High: 271.50
Low: 260.00
Prev. Close: 272.00
GRI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Placing

13 Feb 2020 15:53

RNS Number : 9687C
Grainger PLC
13 February 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

 

 

Grainger plc

("Grainger" or the "Company")

 

 

RESULTS OF PLACING

 

Grainger plc is pleased to announce the successful completion of the placing announced earlier today (the "Placing").

 

A total of 61,200,000 new Ordinary Shares in Grainger (the "Placing Shares") were placed by J.P. Morgan Cazenove and Numis, raising gross proceeds of £186.7 million. Placing Shares have been issued at a price of 305.0 pence per Placing Share. The Placing Shares being issued represent, in aggregate, approximately 9.99 per cent. of Grainger's issued ordinary share capital prior to the Placing.

 

The Placing Price represents a discount of 2.31 per cent. to the closing price on 12 February 2020 of 312.2 pence and a discount of 1.61 per cent. to the intra-day price of 310.0 pence at 11.01 a.m. (being the time the Placing Price was agreed).

 

The Placing Shares will, when issued, be credited as fully paid and rank pari passu with the existing Ordinary Shares, including the right to receive all future dividends and distributions declared, made or paid.

 

Application will be made to the Financial Conduct Authority for admission of the 61,200,000 Placing Shares to the premium listing segment of the Official List maintained by the UK Listing Authority and to London Stock Exchange plc ("LSE") for admission to trading of the Placing Shares on LSE's Main Market for listed securities (together, "Admission"). It is expected that Admission will take place on 17 February 2020 and that dealings in the Placing Shares on the LSE's Main Market for listed securities will commence at the same time.

 

The Placing is conditional, inter alia, upon Admission becoming effective and the Placing Agreement becoming unconditional and not being terminated.

 

Following Admission the total number of voting rights in the Company will be 673,492,299 and 1,506,300 Ordinary Shares are held in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Capitalised terms used but not defined in this announcement have the same meanings as set out in the placing announcement of the Company released at 7.00 a.m. (GMT) on the date hereof.

 

J.P. Morgan Cazenove and Numis acted as joint bookrunners in respect of the Placing.

 

Helen Gordon, Chief Executive Officer of Grainger, commented:

 

 

"We are delighted with the successful outcome of this fundraise which demonstrates the strong support from our shareholders for our ongoing investment in the private rented sector (PRS). This transaction accelerates our PRS growth strategy in London and the regions, and brings forward £246 million of new acquisitions into the secured pipeline, bringing it to c.£1 billion. On completion of the new developments our rental income will grow substantially and this will allow us to further enhance total shareholder returns. We look forward to continuing to deliver quality rental homes in the UK."

 

 

Further enquiries:

 

Grainger plc

Tel: +44 (0) 20 7940 9500

Helen Gordon

Vanessa Simms

 

Kurt Mueller

 

J.P. Morgan Cazenove

Tel: +44 (0) 20 7742 4000

Bronson Albery

 

Barry Meyers

 

Tara Morrison

 

Beau Freker

 

 

Numis

Tel: +44 (0) 20 7260 1000

Heraclis Economides

 

Richard Thomas

 

Ben Stoop

 

George Fry

 

 

Camarco

Tel: +44 (0) 20 3757 4992

Ginny Pulbrook

Geoffrey Pelham Lane

 

Tom Huddart

 

 

 

 

IMPORTANT NOTICE

 

The contents of this announcement have been prepared by and are the sole responsibility of Grainger.

Neither the content of Grainger's website nor any website accessible by hyperlinks on Grainger's website is incorporated in, or forms part of, this announcement.

This announcement is for information purposes only and is directed only at: (a) persons in member states of the EEA who are qualified investors within the meaning of the Prospectus Regulation ("Qualified Investors") (b) persons in the United Kingdom, who are Qualified Investors and (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth companies, unincorporated associations and other persons falling within Article 49(2)(a) to (d) of the Order; and (c) persons to whom it may otherwise by lawfully communicated (all such persons together being referred to as ("Relevant Persons").

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement should not be distributed, forwarded to or transmitted in or into in any jurisdiction where to do so might constitute a violation of local securities laws or regulations, including the United States, Australia, Canada, Japan and South Africa.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States. This announcement does not constitute or form part of an offer of securities for sale or solicitation of an offer to purchase securities in the United States, Australia, Canada, Japan, South Africa or in any other jurisdiction in which such offer may be restricted. The securities referred to in this announcement have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any state in the United States and may not be offered or sold in the United States, except in reliance on an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will be no public offering of securities in the United States.

Each of J.P. Morgan Cazenove, which is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the Financial Conduct Authority (the "FCA") and the PRA, and Numis (together with J.P. Morgan Cazenove, the "Joint Bookrunners"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and no one else in connection with the Placing and will not be responsible to anyone other than the Company for providing the protections afforded to clients of the Joint Bookrunners, nor for providing advice in relation to the Placing or any other matters referred to in this announcement. Neither the Joint Bookrunners nor any of their respective affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, tort or, under statute or otherwise) to any person who is not a client of the Joint Bookrunners in connection with this announcement, any statement contained in herein or otherwise.

This announcement does not constitute a recommendation concerning the Placing. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. The contents of this announcement are not to be construed as legal, business, financial or tax advice. Each shareholder or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

Information to Distributors

 

Solely for the purposes of Article 9(8) of Commission Delegated Directive 2017/593 (the "Delegated Directive") regarding the responsibilities of manufacturers under the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that such Placing Shares are: (i) compatible with the target market for the Placing of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all eligible distribution channels for dissemination of the Placing Shares, each as set out in this Announcement, as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, distributors should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Joint Bookrunners will only procure investors who meet the criteria of professional clients and eligible counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Placing Shares

Each distributor is responsible for undertaking its own target market assessment in respect of the Placing Shares and determining appropriate distribution channels.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIUOSVRRKUUAAR
Date   Source Headline
16th May 20247:00 amRNSHalf year financial results
9th May 202411:02 amRNSDirector/PDMR Shareholding
1st May 202411:57 amRNSTotal Voting Rights
29th Apr 20244:00 pmRNSBlock listing Interim Review
4th Apr 202412:52 pmRNSDirector/PDMR Shareholding
3rd Apr 20247:00 amRNSNotice of Interim Results
7th Mar 20242:52 pmRNSTotal Voting Rights
7th Mar 202411:48 amRNSDirector/PDMR Shareholding
7th Feb 20243:11 pmRNSResult of AGM
7th Feb 20247:00 amRNSTrading Update
6th Feb 202410:09 amRNSDirector/PDMR Shareholding
1st Feb 20244:31 pmRNSTotal Voting Rights
9th Jan 202412:14 pmRNSDirector/PDMR Shareholding
12th Dec 202312:54 pmRNSTotal Voting Rights
12th Dec 202312:46 pmRNSDirector/PDMR Shareholding
12th Dec 202312:44 pmRNSDirector/PDMR Shareholding
6th Dec 20231:49 pmRNSDirector/PDMR Shareholding
22nd Nov 20237:01 amRNSNew BTR partnership with Network Rail & Bloc Group
22nd Nov 20237:00 amRNSFinal Results
6th Nov 20234:12 pmRNSDirector/PDMR Shareholding
6th Oct 20231:09 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSTrading Update
2nd Oct 202311:08 amRNSBlock listing Interim Review
21st Sep 20233:45 pmRNSTotal Voting Rights
7th Sep 20232:53 pmRNSDirector/PDMR Shareholding
8th Aug 20231:03 pmRNSDirector/PDMR Shareholding
25th Jul 20232:20 pmRNSDirector/PDMR Shareholding
5th Jul 202311:35 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Update and Capital Markets Event
7th Jun 20231:31 pmRNSDirector/PDMR Shareholding
25th May 20234:04 pmRNSEBT Purchase
19th May 20234:04 pmRNSEBT purchase
18th May 20237:00 amRNSStatement re Rent Reform Bill
11th May 20237:00 amRNSHalf year financial results
5th May 202312:44 pmRNSDirector/PDMR Shareholding
6th Apr 20232:02 pmRNSDirector/PDMR Shareholding
4th Apr 202310:25 amRNSBlock listing Interim Review
3rd Apr 20237:00 amRNSNotice of Results
13th Mar 202311:57 amRNSTotal Voting Rights
7th Mar 202312:46 pmRNSDirector/PDMR Shareholding
15th Feb 20231:35 pmRNSDirector/PDMR Shareholding
8th Feb 20234:16 pmRNSResult of AGM
8th Feb 20237:00 amRNSTrading Update
7th Feb 202312:12 pmRNSDirector/PDMR Shareholding
7th Feb 202312:08 pmRNSDirector/PDMR Shareholding
6th Feb 20233:14 pmRNSTotal Voting Rights
20th Jan 20235:12 pmRNSAGM Statement
12th Jan 202312:16 pmRNSTotal Voting Rights
10th Jan 20232:33 pmRNSDirector/PDMR Shareholding
13th Dec 20221:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.